Chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer and so on, pose a substantial global health challenge. Environmental pollutants such as cigarette smoke, particulate matter (PM), house dust mite (HDM), silicon, and volatile organic compounds (VOCs) are key contributors to these diseases, yet the underlying mechanisms remain not fully elucidated. PANoptosis, a recently identified form of programmed cell death that integrates apoptosis, pyroptosis, and necroptosis, has emerged as a crucial player in various diseases. PANoptosis is orchestrated by the PANoptosome, a multi-protein complex driven by key sensors such as Z-DNA binding protein 1 (ZBP1), absent in melanoma 2 (AIM2), and receptor-interacting protein kinase 1 (RIPK1). Increasing evidence suggests that PANoptosis contributes to lung diseases progression by exacerbating lung tissue damage in response to environmental pollutants. This review consolidates current findings on PANoptosis in pollutant-induced chronic respiratory diseases, which might provide new insights into underlying mechanisms and potential therapeutic targets.
MomtazmaneshSMoghaddamSSGhamariSH, et al. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the global burden of disease study 2019. EClinicalMedicine2023; 59: 101936.
2.
LeiterAVeluswamyRRWisniveskyJP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol2023; 20(9): 624–639.
3.
ParkYCChoiSYChaY, et al. Microbiome-mucosal immunity nexus: driving forces in respiratory disease progression. J Microbiol2024; 62(9): 709–725.
4.
WuHEckhardtCMBaccarelliAA. Molecular mechanisms of environmental exposures and human disease. Nat Rev Genet2023; 24(5): 332–344.
5.
SayersIJohnCChenJ, et al. Genetics of chronic respiratory disease. Nat Rev Genet2024; 25(8): 534–547.
6.
LaiWLiGPengD, et al. Mendelian randomization study reveals the relationship between dietary factors and respiratory diseases. Sci Rep2023; 13(1): 22601.
7.
FitzpatrickMESethiSDaleyCL, et al. Infections in “noninfectious” lung diseases. Ann Am Thorac Soc2014; 11(Suppl. 4): S221–S226.
8.
MaungTZBishopJEHoltE, et al. Indoor air pollution and the health of vulnerable groups: a systematic review focused on particulate matter (PM), volatile organic compounds (VOCs) and their effects on children and people with pre-existing lung disease. Int J Environ Res Public Health2022; 19(14): 8752.
9.
LuggSTScottAParekhD, et al. Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease. Thorax2022; 77(1): 94–101.
10.
VankaKSShuklaSGomezHM, et al. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. Eur Respir Rev2022; 31(165): 210250.
11.
JohnsonJRWileyREFattouhR, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med2004; 169(3): 378–385.
12.
XueYWangLZhangY, et al. Air pollution: a culprit of lung cancer. J Hazard Mater2022; 434: 128937.
13.
Arias-PérezRDTabordaNAGómezDM, et al. Inflammatory effects of particulate matter air pollution. Environ Sci Pollut Res Int2020; 27(34): 42390–43404.
14.
HouTZhuLWangY, et al. Oxidative stress is the pivot for PM2.5-induced lung injury. Food Chem Toxicol2024; 184: 114362.
15.
WangBChanY-LLiG, et al. Maternal particulate matter exposure impairs lung health and is associated with mitochondrial damage. Antioxidants (Basel)2021; 10(7): 1029.
16.
LiuXZhaoXLiX, et al. PM2.5 triggered apoptosis in lung epithelial cells through the mitochondrial apoptotic way mediated by a ROS-DRP1-mitochondrial fission axis. J Hazard Mater2020; 397: 122608.
17.
FanXGaoYHuaC, et al. Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice. Biomed Pharmacother2023; 165: 115047.
18.
SagawaTIchinoseTHondaA, et al. Acceleration of acute lung inflammation by IL-1α released through cell death of alveolar macrophages upon phagocytosis of fine Asian sand dust particles. Environ Int2024; 194: 109178.
19.
SunXYangYMengX, et al. PANoptosis: mechanisms, biology, and role in disease. Immunol Rev2024; 321(1): 246–262.
20.
SamirPMalireddiRKSKannegantiT-D. The PANoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol2020; 10: 238.
21.
XiangQGengZ-XYiX, et al. PANoptosis: a novel target for cardiovascular diseases. Trends Pharmacol Sci2024; 45(8): 739–756.
22.
ChenSJiangJLiT, et al. PANoptosis: mechanism and role in pulmonary diseases. Int J Mol Sci2023; 24(20): 15343.
23.
MiaoLYWangXHanYY. Research progress on the role and mechanism of PANoptosis in liver diseases. Zhonghua Gan Zang Bing Za Zhi2024; 32(11): 1047–1052.
24.
HouYFengQWeiC, et al. Emerging role of PANoptosis in kidney diseases: molecular mechanisms and therapeutic opportunities. Apoptosis2025; 30: 579–596.
25.
QiuYFanYHuangG, et al. N6-methyladenosine demethylase ALKBH5 homologous protein protects against cerebral I/R injury though suppressing SNHG3-mediated neural PANoptosis: Involvement of m6A-related macromolecules in the diseases of nervous system. Int J Biol Macromol2024; 274(Pt. 2): 133815.
26.
Messaoud-NacerYCulerierERoseS, et al. STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite. Allergy2025; 80: 715–737.
27.
XiaHLinJWangY, et al. Stenotrophomonas maltophilia contributes to smoking-related emphysema through IRF1-triggered PANoptosis of alveolar epithelial cells. Environ Pollut2024; 349: 123913.
28.
LiuQNiuYPeiZ, et al. Gas6-Axl signal promotes indoor VOCs exposure-induced pulmonary fibrosis via pulmonary microvascular endothelial cells-fibroblasts cross-talk. J Hazard Mater2024; 474: 134786.
29.
MaWXuLWangY, et al. piR-27222 mediates PM2.5-induced lung cancer by resisting cell PANoptosis through the WTAP/m6A axis. Environ Int2024; 190: 108928.
30.
WāngY. Ambient fine particulate matter provokes multiple modalities of cell death via perturbation of subcellular structures. Environ Int2025; 195: 109193.
31.
YuanJOfengeimD. A guide to cell death pathways. Nat Rev Mol Cell Biol2024; 25(5): 379–395.
32.
SarasteAPulkkiK. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res2000; 45(3): 528–537.
33.
YangQLiSFuZ, et al. Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma. Mol Med Rep2017; 16(2): 1347–1352.
34.
LiuXZhangZRuanJ, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature2016; 535(7610): 153–158.
35.
WeiXXieFZhouX, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol2022; 19(9): 971–992.
36.
PasparakisMVandenabeeleP. Necroptosis and its role in inflammation. Nature2015; 517(7534): 311–320.
37.
QiZZhuLWangK, et al. PANoptosis: emerging mechanisms and disease implications. Life Sci2023; 333: 122158.
38.
ShiCCaoPWangY, et al. PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis. J Inflamm Res2023; 16: 1523–1532.
39.
ZhuPKeZ-RChenJ-X, et al. Advances in mechanism and regulation of PANoptosis: prospects in disease treatment. Front Immunol2023; 14: 1120034.
40.
ChristgenSZhengMKesavardhanaS, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol2020; 10: 237.
41.
JiaoHWachsmuthLKumariS, et al. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature2020; 580(7803): 391–395.
42.
NewtonKWickliffeKEDuggerDL, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature2019; 574(7778): 428–431.
43.
OhSLeeJOhJ, et al. Integrated NLRP3, AIM2, NLRC4, pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol2023; 20(12): 1513–1526.
44.
KesavardhanaSMalireddiRKSKannegantiT-D. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol2020; 38: 567–595.
45.
ShiJZhaoYWangK, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature2015; 526(7575): 660–665.
46.
LiangLWangWChenJ, et al. SARS-CoV-2 N protein induces acute kidney injury in diabetic mice via the Smad3-Ripk3/MLKL necroptosis pathway. Signal Transduct Target Ther2023; 8(1): 147.
47.
PapiABrightlingCPedersenSE, et al. Asthma. Lancet2018; 391(10122): 783–800.
TiotiuAINovakovaPNedevaD, et al. Impact of air pollution on asthma outcomes. Int J Environ Res Public Health2020; 17(17): 6212.
50.
LeeJXPhipatanakulWGaffinJM. Environment and the development of severe asthma in inner city population. Curr Opin Allergy Clin Immunol2023; 23(2): 179–184.
51.
GrantTLWoodRA. The influence of urban exposures and residence on childhood asthma. Pediatr Allergy Immunol2022; 33(5): e13784.
52.
HeXZhangLHuL, et al. PM2.5 Aggravated OVA-induced epithelial tight junction disruption through fas associated via death domain-dependent apoptosis in asthmatic mice. J Asthma Allergy2021; 14: 1411–1423.
53.
ZhuangJCuiHZhuangL, et al. Bronchial epithelial pyroptosis promotes airway inflammation in a murine model of toluene diisocyanate-induced asthma. Biomed Pharmacother2020; 125: 109925.
54.
OikonomouNSchuijsMJChatzigiagkosA, et al. Airway epithelial cell necroptosis contributes to asthma exacerbation in a mouse model of house dust mite-induced allergic inflammation. Mucosal Immunol2021; 14(5): 1160–1171.
55.
UrbaniFCometaMMartelliC, et al. Update on virus-induced asthma exacerbations. Expert Rev Clin Immunol2023; 19(10): 1259–1272.
56.
Skopelja-GardnerSAnJElkonKB. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nat Rev Nephrol2022; 18(9): 558–572.
57.
CaoQJuanC-XZhangD-Q, et al. STING positively regulates human ORMDL3 expression through TBK1-IRF3-STAT6 complex mediation. Exp Cell Res2018; 370(2): 498–505.
58.
Messaoud-NacerYCulerierERoseS, et al. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death Dis2022; 13(3): 269.
59.
HuangHQiaoYChuL, et al. Up-regulation of HSP90α in HDM-induced asthma causes pyroptosis of airway epithelial cells by activating the cGAS-STING-ER stress pathway. Int Immunopharmacol2024; 131: 111917.
60.
PauwelsRARabeKF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet2004; 364(9434): 613–620.
61.
WilgusMLAbtinFMarkovicD, et al. Panlobular emphysema is associated with COPD disease severity: a study of emphysema subtype by computed tomography. Respir Med2022; 192: 106717.
62.
LabakiWWRosenbergSR. Chronic obstructive pulmonary disease. Ann Intern Med2020; 173(3): ITC17–ITC32.
63.
HoltjerJCSBloemsmaLDBeijersRJHCG, et al. Identifying risk factors for COPD and adult-onset asthma: an umbrella review. Eur Respir Rev2023; 32(168): 230009.
64.
GongJZhaoHLiuT, et al. Cigarette smoke reduces fatty acid catabolism, leading to apoptosis in lung endothelial cells: implication for pathogenesis of COPD. Front Pharmacol2019; 10: 941.
65.
ZhangM-YJiangY-XYangY-C, et al. Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway. Life Sci2021; 269: 119090.
66.
MizumuraKCloonanSMNakahiraK, et al. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J Clin Invest2014; 124(9): 3987–4003.
67.
ZhaoJLiMWangZ, et al. Role of PM2.5 in the development and progression of COPD and its mechanisms. Respir Res2019; 20(1): 120.
68.
GuoXLinYLinY, et al. PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification. Environ Pollut2022; 303: 119115.
69.
ChungCParkSYHuhJ-Y, et al. Fine particulate matter aggravates smoking induced lung injury via NLRP3/caspase-1 pathway in COPD. J Inflamm (Lond)2024; 21(1): 13.
70.
ShiRLiangRWangF, et al. Identification and experimental validation of PYCARD as a crucial PANoptosis-related gene for immune response and inflammation in COPD. Apoptosis2024; 29(11–12): 2091–2107.
71.
KarakasidisEKotsiouOSGourgoulianisKI. Lung and gut microbiome in COPD. J Pers Med2023; 13(5): 804.
72.
SulaimanIWuBGChungM, et al. Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med2023; 208(10): 1101–1114.
73.
LaimanVChuangH-CLoY-C, et al. Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients. Respir Res2024; 25(1): 204.
74.
RønnCKamstrupPEklöfJ, et al. Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients. Respir Res2023; 24(1): 232.
ShahabiRDehghaniMJavad MoosaviSA, et al. The effect of nanoparticles on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies. Arch Environ Occup Health2022; 77(8): 684–694.
77.
GandhiSTonelliRMurrayM, et al. Environmental causes of idiopathic pulmonary fibrosis. Int J Mol Sci2023; 24(22): 16481.
78.
PangXShiHChenX, et al. miRNA-34c-5p targets Fra-1 to inhibit pulmonary fibrosis induced by silica through p53 and PTEN/PI3K/Akt signaling pathway. Environ Toxicol2022; 37(8): 2019–2032.
79.
TianJSongDPengY, et al. Silica-induced macrophage pyroptosis propels pulmonary fibrosis through coordinated activation of relaxin and osteoclast differentiation signaling to reprogram fibroblasts. Ecotoxicol Environ Saf2024; 273: 116106.
80.
ChoiJ-YKangMJungJ-H, et al. Exposure of lung fibroblasts to PM2.5 and lead (Pb) induces fibrosis and apoptosis in alveolar epithelial cells via a paracrine effect. Ecotoxicol Environ Saf2024; 288: 117401.
81.
ZhangYLiAGaoJ, et al. Differences in the characteristics and pulmonary toxicity of nano- and micron-sized respirable coal dust. Respir Res2022; 23(1): 197.
82.
ChenHXiaZQingB, et al. Molecular characterization of PANoptosis-related genes associated with immune infiltration and prognosis in idiopathic pulmonary fibrosis. Int Immunopharmacol2024; 143(Pt. 3): 113572.
83.
KimSChoiY-KParkK-W, et al. Test methods and reduction of organic pollutant compound emissions from wood-based building and furniture materials. Bioresour Technol2010; 101(16): 6562–6568.
84.
ThaiAASolomonBJSequistLV, et al. Lung cancer. Lancet2021; 398(10299): 535–554.
85.
NicholsonAGTsaoMSBeasleyMB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol2022; 17(3): 362–387.
86.
FedelePSantoroANPiniF, et al. Immunonutrition, metabolism, and programmed cell death in lung cancer: translating bench to bedside. Biology (Basel)2024; 13(6): 409.
87.
HeuschWLManeckjeeR. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis1998; 19(4): 551–556.
88.
WhangYMJoUSungJS, et al. Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C. PLoS One2013; 8(1): e53012.
89.
SunH-NRenC-XGongY-X, et al. Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development. Oncol Lett2021; 21(6): 465.
90.
XuLMaWHuoX, et al. New insights into the function and mechanisms of piRNA PMLCPIR in promoting PM2.5-induced lung cancer. J Adv Res2025; 73: 659–670.
91.
MukherjeePBhattacharjeeSMandalDP. PIWI-interacting RNA (piRNA): a narrative review of its biogenesis, function, and emerging role in lung cancer. Asian Biomed (Res Rev News)2022; 16(1): 3–14.
92.
DiaoM-NZhangX-JZhangY-F. The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy. Br J Cancer2023; 129(1): 8–23.
